Early detection of emergent extensively drug-resistant tuberculosis by flow cytometry-based phenotyping and whole-genome sequencing

Max R. O’Donnell, Michelle H. Larsen, Tyler S. Brown, Paras Jain, Vanisha Munsamy, Allison Wolf, Lorenzo Uccellini, Farina Karim, Tulio de Oliveira, Barun Mathema, William R. Jacobs, Alexander Pym

Research output: Contribution to journalArticle

Abstract

A critical gap in tuberculosis (TB) treatment is detection of emergent drug resistance. We hypothesized that advanced phenotyping with whole-genome sequencing (WGS) will detect low-frequency Mycobacterium tuberculosis drug resistance. We assessed a reporter mycobacteriophage ( 2 GFP10) in vitro to detect drug-resistant subpopulations and predict M. tuberculosis bactericidal activity in this pilot study. Subsequently, we prospectively studied 20 TB patients with serial 2 GFP10, Xpert MTB/RIF, and M. tuberculosis culture through end of treatment. WGS was performed, and single nucleotide polymorphisms (SNPs) were examined to detect mixed infection in selected M. tuberculosis isolates. Resistant M. tuberculosis isolates were detected at 1:100,000, and changes in cytometry-gated events were predictive of in vitro M. tuberculosis bactericidal activity using the 2 GFP10 assay. Emergent drug resistance was detected in one patient by 2 GFP10 at 3 weeks but not by conventional testing (M. tuberculosis culture and GeneXpert). WGS revealed a phylogeo-graphically distinct extensively drug-resistant tuberculosis (XDR-TB) genome, identical to an XDR-TB isolate from the patient’s spouse. Variant lineage-specific SNPs were present early, suggesting mixed infection as the etiology of emergent resistance with temporal trends providing evidence for selection during treatment. 2 GFP10 can detect low-frequency drug-resistant M. tuberculosis and with WGS characterize emergent M. tuberculosis resistance. In areas of high TB transmission and drug resistance, rapid screening for heteroresistance should be considered.

Original languageEnglish (US)
Article numbere01834-18
JournalAntimicrobial Agents and Chemotherapy
Volume63
Issue number4
DOIs
StatePublished - Apr 1 2019

Fingerprint

Extensively Drug-Resistant Tuberculosis
Mycobacterium tuberculosis
Flow Cytometry
Genome
Tuberculosis
Drug Resistance
Coinfection
Single Nucleotide Polymorphism
Mycobacteriophages
Multidrug-Resistant Tuberculosis
Mycobacterium
Spouses
Therapeutics

Keywords

  • Extensively drug-resistant tuberculosis
  • Heteroresistance
  • Phage
  • South Africa
  • Tuberculosis
  • Whole-genome sequencing

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Early detection of emergent extensively drug-resistant tuberculosis by flow cytometry-based phenotyping and whole-genome sequencing. / O’Donnell, Max R.; Larsen, Michelle H.; Brown, Tyler S.; Jain, Paras; Munsamy, Vanisha; Wolf, Allison; Uccellini, Lorenzo; Karim, Farina; de Oliveira, Tulio; Mathema, Barun; Jacobs, William R.; Pym, Alexander.

In: Antimicrobial Agents and Chemotherapy, Vol. 63, No. 4, e01834-18, 01.04.2019.

Research output: Contribution to journalArticle

O’Donnell, MR, Larsen, MH, Brown, TS, Jain, P, Munsamy, V, Wolf, A, Uccellini, L, Karim, F, de Oliveira, T, Mathema, B, Jacobs, WR & Pym, A 2019, 'Early detection of emergent extensively drug-resistant tuberculosis by flow cytometry-based phenotyping and whole-genome sequencing', Antimicrobial Agents and Chemotherapy, vol. 63, no. 4, e01834-18. https://doi.org/10.1128/AAC.01834-18
O’Donnell, Max R. ; Larsen, Michelle H. ; Brown, Tyler S. ; Jain, Paras ; Munsamy, Vanisha ; Wolf, Allison ; Uccellini, Lorenzo ; Karim, Farina ; de Oliveira, Tulio ; Mathema, Barun ; Jacobs, William R. ; Pym, Alexander. / Early detection of emergent extensively drug-resistant tuberculosis by flow cytometry-based phenotyping and whole-genome sequencing. In: Antimicrobial Agents and Chemotherapy. 2019 ; Vol. 63, No. 4.
@article{553dfb7823c845e18ceee04a6e793f99,
title = "Early detection of emergent extensively drug-resistant tuberculosis by flow cytometry-based phenotyping and whole-genome sequencing",
abstract = "A critical gap in tuberculosis (TB) treatment is detection of emergent drug resistance. We hypothesized that advanced phenotyping with whole-genome sequencing (WGS) will detect low-frequency Mycobacterium tuberculosis drug resistance. We assessed a reporter mycobacteriophage ( 2 GFP10) in vitro to detect drug-resistant subpopulations and predict M. tuberculosis bactericidal activity in this pilot study. Subsequently, we prospectively studied 20 TB patients with serial 2 GFP10, Xpert MTB/RIF, and M. tuberculosis culture through end of treatment. WGS was performed, and single nucleotide polymorphisms (SNPs) were examined to detect mixed infection in selected M. tuberculosis isolates. Resistant M. tuberculosis isolates were detected at 1:100,000, and changes in cytometry-gated events were predictive of in vitro M. tuberculosis bactericidal activity using the 2 GFP10 assay. Emergent drug resistance was detected in one patient by 2 GFP10 at 3 weeks but not by conventional testing (M. tuberculosis culture and GeneXpert). WGS revealed a phylogeo-graphically distinct extensively drug-resistant tuberculosis (XDR-TB) genome, identical to an XDR-TB isolate from the patient’s spouse. Variant lineage-specific SNPs were present early, suggesting mixed infection as the etiology of emergent resistance with temporal trends providing evidence for selection during treatment. 2 GFP10 can detect low-frequency drug-resistant M. tuberculosis and with WGS characterize emergent M. tuberculosis resistance. In areas of high TB transmission and drug resistance, rapid screening for heteroresistance should be considered.",
keywords = "Extensively drug-resistant tuberculosis, Heteroresistance, Phage, South Africa, Tuberculosis, Whole-genome sequencing",
author = "O’Donnell, {Max R.} and Larsen, {Michelle H.} and Brown, {Tyler S.} and Paras Jain and Vanisha Munsamy and Allison Wolf and Lorenzo Uccellini and Farina Karim and {de Oliveira}, Tulio and Barun Mathema and Jacobs, {William R.} and Alexander Pym",
year = "2019",
month = "4",
day = "1",
doi = "10.1128/AAC.01834-18",
language = "English (US)",
volume = "63",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "4",

}

TY - JOUR

T1 - Early detection of emergent extensively drug-resistant tuberculosis by flow cytometry-based phenotyping and whole-genome sequencing

AU - O’Donnell, Max R.

AU - Larsen, Michelle H.

AU - Brown, Tyler S.

AU - Jain, Paras

AU - Munsamy, Vanisha

AU - Wolf, Allison

AU - Uccellini, Lorenzo

AU - Karim, Farina

AU - de Oliveira, Tulio

AU - Mathema, Barun

AU - Jacobs, William R.

AU - Pym, Alexander

PY - 2019/4/1

Y1 - 2019/4/1

N2 - A critical gap in tuberculosis (TB) treatment is detection of emergent drug resistance. We hypothesized that advanced phenotyping with whole-genome sequencing (WGS) will detect low-frequency Mycobacterium tuberculosis drug resistance. We assessed a reporter mycobacteriophage ( 2 GFP10) in vitro to detect drug-resistant subpopulations and predict M. tuberculosis bactericidal activity in this pilot study. Subsequently, we prospectively studied 20 TB patients with serial 2 GFP10, Xpert MTB/RIF, and M. tuberculosis culture through end of treatment. WGS was performed, and single nucleotide polymorphisms (SNPs) were examined to detect mixed infection in selected M. tuberculosis isolates. Resistant M. tuberculosis isolates were detected at 1:100,000, and changes in cytometry-gated events were predictive of in vitro M. tuberculosis bactericidal activity using the 2 GFP10 assay. Emergent drug resistance was detected in one patient by 2 GFP10 at 3 weeks but not by conventional testing (M. tuberculosis culture and GeneXpert). WGS revealed a phylogeo-graphically distinct extensively drug-resistant tuberculosis (XDR-TB) genome, identical to an XDR-TB isolate from the patient’s spouse. Variant lineage-specific SNPs were present early, suggesting mixed infection as the etiology of emergent resistance with temporal trends providing evidence for selection during treatment. 2 GFP10 can detect low-frequency drug-resistant M. tuberculosis and with WGS characterize emergent M. tuberculosis resistance. In areas of high TB transmission and drug resistance, rapid screening for heteroresistance should be considered.

AB - A critical gap in tuberculosis (TB) treatment is detection of emergent drug resistance. We hypothesized that advanced phenotyping with whole-genome sequencing (WGS) will detect low-frequency Mycobacterium tuberculosis drug resistance. We assessed a reporter mycobacteriophage ( 2 GFP10) in vitro to detect drug-resistant subpopulations and predict M. tuberculosis bactericidal activity in this pilot study. Subsequently, we prospectively studied 20 TB patients with serial 2 GFP10, Xpert MTB/RIF, and M. tuberculosis culture through end of treatment. WGS was performed, and single nucleotide polymorphisms (SNPs) were examined to detect mixed infection in selected M. tuberculosis isolates. Resistant M. tuberculosis isolates were detected at 1:100,000, and changes in cytometry-gated events were predictive of in vitro M. tuberculosis bactericidal activity using the 2 GFP10 assay. Emergent drug resistance was detected in one patient by 2 GFP10 at 3 weeks but not by conventional testing (M. tuberculosis culture and GeneXpert). WGS revealed a phylogeo-graphically distinct extensively drug-resistant tuberculosis (XDR-TB) genome, identical to an XDR-TB isolate from the patient’s spouse. Variant lineage-specific SNPs were present early, suggesting mixed infection as the etiology of emergent resistance with temporal trends providing evidence for selection during treatment. 2 GFP10 can detect low-frequency drug-resistant M. tuberculosis and with WGS characterize emergent M. tuberculosis resistance. In areas of high TB transmission and drug resistance, rapid screening for heteroresistance should be considered.

KW - Extensively drug-resistant tuberculosis

KW - Heteroresistance

KW - Phage

KW - South Africa

KW - Tuberculosis

KW - Whole-genome sequencing

UR - http://www.scopus.com/inward/record.url?scp=85063646221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063646221&partnerID=8YFLogxK

U2 - 10.1128/AAC.01834-18

DO - 10.1128/AAC.01834-18

M3 - Article

VL - 63

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 4

M1 - e01834-18

ER -